Adding trastuzumab to standard chemotherapy in HER2-positive esophagogastric adenocarcinoma: a further step toward personalized medicine

Gastroenterology. 2011 Jan;140(1):356-8; discussion 358. doi: 10.1053/j.gastro.2010.11.011. Epub 2010 Nov 16.

No abstract available

Publication types